The Silent Revolution: Karyopharm’s Bold Leap in Cancer Therapy
Karyopharm Therapeutics Inc., based in Newton, Massachusetts, focuses on innovative cancer treatments, especially nuclear export dysregulation. Its flagship product, XPOVIO® (selinexor), offers promising treatment options for cancers with limited alternatives, reaching patients globally. The company recently welcomed new team members, offering them
